Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
Marco Segatto, Raffaella Fittipaldi, Fabrizio Pin, et al.
Nature Communications (2017) Vol. 8, Iss. 1
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Mechanisms of muscle atrophy and hypertrophy: implications in health and disease
Roberta Sartori, Vanina Romanello, Marco Sandri
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 612
The BET family in immunity and disease
Nian Wang, Runliu Wu, Daolin Tang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 216
Signaling Pathways That Control Muscle Mass
Anna Vainshtein, Marco Sandri
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 13, pp. 4759-4759
Open Access | Times Cited: 156
Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome
Olga Sukocheva, Rebekah Maksoud, Narasimha M. Beeraka, et al.
Journal of Advanced Research (2021) Vol. 40, pp. 179-196
Open Access | Times Cited: 143
Molecular mechanisms of cancer cachexia‐related loss of skeletal muscle mass: data analysis from preclinical and clinical studies
Agnès Martin, Yann S. Gallot, Damien Freyssenet
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 3, pp. 1150-1167
Open Access | Times Cited: 48
Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?
Marc Hilmi, Anne Jouinot, Robert Burns, et al.
Pharmacology & Therapeutics (2018) Vol. 196, pp. 135-159
Open Access | Times Cited: 120
Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
Wenxiao Jiang, Jun Xia, Shangdan Xie, et al.
Drug Resistance Updates (2020) Vol. 50, pp. 100683-100683
Closed Access | Times Cited: 115
BRD4 Promotes Gastric Cancer Progression and Metastasis through Acetylation-Dependent Stabilization of Snail
Zhong‐yi Qin, Tao Wang, Siyuan Su, et al.
Cancer Research (2019) Vol. 79, Iss. 19, pp. 4869-4881
Closed Access | Times Cited: 107
Animal models of sarcopenia
Courtney J. Christian, Guy M. Benian
Aging Cell (2020) Vol. 19, Iss. 10
Open Access | Times Cited: 94
Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench
Neda Naderi, Carola‐Ellen Kleine, Christina Park, et al.
Progress in Cardiovascular Diseases (2018) Vol. 61, Iss. 2, pp. 168-181
Open Access | Times Cited: 91
Inhibitors of bromodomain and extra‐terminal proteins for treating multiple human diseases
Ewelina Kulikowski, Brooke D. Rakai, Norman C.W. Wong
Medicinal Research Reviews (2020) Vol. 41, Iss. 1, pp. 223-245
Open Access | Times Cited: 91
Phenotypic features of cancer cachexia‐related loss of skeletal muscle mass and function: lessons from human and animal studies
Agnès Martin, Damien Freyssenet
Journal of Cachexia Sarcopenia and Muscle (2021) Vol. 12, Iss. 2, pp. 252-273
Open Access | Times Cited: 65
AMPK as a mediator of tissue preservation: time for a shift in dogma?
Henning T. Langer, Maria Rohm, Marcus D. Goncalves, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 9, pp. 526-540
Closed Access | Times Cited: 12
SMYD3 promotes the epithelial–mesenchymal transition in breast cancer
Claudio Fenizia, Cinzia Bottino, Silvia Corbetta, et al.
Nucleic Acids Research (2018) Vol. 47, Iss. 3, pp. 1278-1293
Open Access | Times Cited: 82
Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression
Weidong Shi, Chenyue Zhang, Zhouyu Ning, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 76
Bromodomain inhibitor jq1 induces cell cycle arrest and apoptosis of glioma stem cells through the VEGF/PI3K/AKT signaling pathway
Naiyan Wen, Baofeng Guo, Hongwu Zheng, et al.
International Journal of Oncology (2019)
Open Access | Times Cited: 75
Mitochondrial dynamics in cancer-induced cachexia
Miranda van der Ende, Sander Grefte, Rogier L.C. Plas, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2018) Vol. 1870, Iss. 2, pp. 137-150
Open Access | Times Cited: 70
BET bromodomain inhibition attenuates cardiac phenotype in myocyte-specific lamin A/C–deficient mice
Gaëlle Auguste, Leila Rouhi, Scot J. Matkovich, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 9, pp. 4740-4758
Open Access | Times Cited: 59
Epigenetics of Sepsis
Alexandra Binnie, Jennifer Tsang, Pingzhao Hu, et al.
Critical Care Medicine (2020) Vol. 48, Iss. 5, pp. 745-756
Closed Access | Times Cited: 56
Musclin, A Myokine Induced by Aerobic Exercise, Retards Muscle Atrophy During Cancer Cachexia in Mice
Andrea David Re Cecconi, Mara Forti, Michela Chiappa, et al.
Cancers (2019) Vol. 11, Iss. 10, pp. 1541-1541
Open Access | Times Cited: 55
Activating transcription factor 4 (ATF4) promotes skeletal muscle atrophy by forming a heterodimer with the transcriptional regulator C/EBPβ
Scott M. Ebert, Steven A. Bullard, Nathan Basisty, et al.
Journal of Biological Chemistry (2020) Vol. 295, Iss. 9, pp. 2787-2803
Open Access | Times Cited: 52
Adenosine monophosphate‐activated protein kinase is elevated in human cachectic muscle and prevents cancer‐induced metabolic dysfunction in mice
Steffen H. Raun, Mona S. Ali, Xiuqing Han, et al.
Journal of Cachexia Sarcopenia and Muscle (2023) Vol. 14, Iss. 4, pp. 1631-1647
Open Access | Times Cited: 17
BET bromodomain inhibitors: fragment-based in silico design using multi-target QSAR models
Alejandro Speck‐Planche, Luciana Scotti
Molecular Diversity (2018) Vol. 23, Iss. 3, pp. 555-572
Closed Access | Times Cited: 51
BETs inhibition attenuates oxidative stress and preserves muscle integrity in Duchenne muscular dystrophy
Marco Segatto, Roberta Szokoll, Raffaella Fittipaldi, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 46
Discovery of potent BET bromodomain 1 stereoselective inhibitors using DNA-encoded chemical library selections
Ram K. Modukuri, Zhifeng Yu, Zhi Tan, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 22
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top